Anticoagulant Use In Hospice

Outline:

Recognize the risk factors of venous thromboembolism (VTE) in patients with and without cancer

- VTE risk factors (patients without cancer)

- VTE risk factors (patients with cancer)

- Incidence of VTE

- Hospice patients and evidence

Assess risk of anticoagulant-induced adverse drug event (ADE) based on patient-specific factors

- Anticoagulant agents

- Indications

- Duration of use

- Risk factors for bleeding

- Benefits of use

- Cost and other product considerations

Evaluate benefits and risks of both continuing and discontinuing anticoagulant therapy to make a balanced decision based on patient goals of care

- Deprescibing at end-of-life

- Deprescribing anticoagulants

- Patient case #1

- Review of switching between anticoagulants

- Patient case #2

- Considering discontinuation

As Clinical Pharmacy Lead at Enclara Pharmacia, Marisa serves as a clinical leadership resource with an aim of enhancing the training and enrichment of the Patient Care Operations pharmacist team. She also maintains extensive experience and knowledge of pharmacy practice in hospice and palliative care to support communications and stay abreast of changes in practice that impact patients. Marisa has over 20 years of experience as a pharmacist in various fields including 17 years of hospice pharmacy experience, as well as clinical roles in both the hospital and home infusion settings. Throughout Marisa’s career, she has been continuously involved in the education and training of healthcare professionals and students. Marisa earned her Doctor of Pharmacy degree at Wilkes University, Nesbitt School of Pharmacy and recently earned a Master of Science degree in palliative care from the University of Maryland, Baltimore. She completed a 1-year post-graduate pharmacy practice residency program and maintains certification as a Board-Certified Pharmacotherapy Specialist (BCPS).